Vaccine testing for coronavirus in beginning stages
SEATTLE, W.A. — Testing for an experimental coronavirus vaccine is officially underway in the United States.
The phase 1 clinical trial began Monday at the Kaiser Permanente Washington Health Research Institute in Seattle.
The trial involves a total of 45 volunteers who will be given two doses of the potential vaccine called “Mrna-1273”. The first dose was administrated to the first person today.
Even if the trial goes well, experts say a vaccine would not be available for widespread use for at least a year.
Scientists say the shots do not contain the virus, so the volunteers will not get infected with COVID-19 as a result of the trial.